Recent Blog Posts

View Post: New developments in pancreatic cancer @AACR - Pharma Strategy Blog
24 Nov 2009 by MaverickNY  
Recently, Nab-paclitaxel (abraxane) has been granted orphan drug status in pancreatic and melanoma cancers. The rationale for using Nab-paclitaxel in pancreatic cancer is that it appears to weaken the stroma surrounding the tumour and ...
View Blog: Pharma Strategy Blog - http://www.pharmastrategyblog.com/

---

View Post: A phase I trial of paclitaxel and trastuzumab in combination with ...
10 Nov 2009 by Bekaii-Saab, TS, Roda, JM, Guenterberg,...  
IL-12 in combination with trastuzumab and paclitaxel therefore exhibits an acceptable toxicity profile and has activity in patients with HER2-overexpressing cancers. [Mol Cancer Ther 2009;8(11):2983–91]. Keywords ...
View Blog: Molecular Cancer Therapeutics current issue - http://mct.aacrjournals.org/

---

View Post: Independent Review of E2100: A Phase III Trial of Bevacizumab Plus ...
16 Oct 2009 by Gray, Bhattacharya, Bowden, Miller, Comis  
Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer. Robert Gray, Suman Bhattacharya, Christopher Bowden, Kathy Miller, Robert L. Comis ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: Cancer Drug News Editor's Blog: Various positive data disclosed at ...
16 hours ago by Alice Rossiter  
Separately, updated results from a Phase I/II trial (REO 011) of Oncolytics Biotech's Reolysin combined with carboplatin and paclitaxel (CP) for patients with advanced cancer, with a focus on H&N cancer, demonstrated that Reolysin was ...
View Blog: Cancer Drug News Editor's Blog - http://cancerdrugnewsblog.blogspot.com/

---

View Post: Gene increases effectiveness of drugs used to fight cancer and ...
24 Nov 2009 by admin  
Thus, in lung cancer cell line A-549, scientists from the UGR achieved a 14% inhibition of tumour growth and reduced by 100 times the dose of Paclitaxel agent when it was combined with gene E. In the case of colon cancer, ...
View Blog: BreakThrough Digest Medical News - http://www.breakthroughdigest.com/

---

View Post: Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With ...
18 Nov 2009 by Sandi Pniauskas  
2009] - PubMed result CONCLUSION: The regimen of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab is feasible, safe, and worthy of future study in advanced ovarian cancer. ovarian+cancer. Technorati Blog Finder ...
View Blog: OVARIAN CANCER and US - http://ovariancancerandus.blogspot.com/

---

View Post: Med-Chemist: Oncolytics Biotech's REOLYSIN combined with pac ...
3 hours ago by Digg RSS Search for cancer  
Check out Med-Chemist: Oncolytics Biotech's REOLYSIN combined with paclitaxel and carboplatin well tolerated for advanced cancers at http://synchemist.blogspot.com/2009/11/oncolytics-biotechs-reolysin-combined.html. ... Search Alternative Cancer Remedies. AssociateNET Collection by CureologyPublishing ...
View Blog: Cancer News Today - http://www.cancernewstoday.com/

---

View Post: Roche Holding AG , Genentech (South SF) Apply for Avastin Advanced ...
17 Nov 2009
Avastin is currently approved in combination with paclitaxel chemotherapy for first-line treatment of advanced HER2-negative breast cancer. This approval was based on results of the Phase III E2100 study and granted under the FDA's ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---